CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change
- NT 10-K Other NT 10-K
- 4 Open-market buy Co-President & COO bought 115,200 shares at an average $0.13 ($14,694)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy COO bought 121,000 shares at an average $0.13 ($15,285)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 32,500 shares at $0.05 ($1,625)
- 3/A Insider 3/A
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy Director bought 139,200 shares at an average $0.22 ($30,916)
- 4 Other acquisition Director acquired 3,760,983 shares (other)
- 4 Open-market buy COO bought 15,609 shares at an average $0.13 ($2,023)
Page 3 of 63 · 1,250 filings